Ben Marsh

• The underwriters of Owlet’s $35 million offering of Class A common stock and the financial advisor in Owlet’s exchange of Series A warrants and Series B warrants for newly issued common stock
• OncoC4 in its $47 million preferred stock financing
• The initial purchasers of KalVista Pharmaceuticals’ $144 million convertible senior notes due 2031
• The agent for Quantum SI’s $100 million at-the-market offering
• The agent for Cormedix Inc.’s $150 million private placement of convertible senior notes due 2030
• Compass Pathways in multiple underwritten public offerings of American Depositary Shares and pre-funded warrants in lieu of ADSs, and warrants to purchase ADSs, for total proceeds of up to approximately $800 million
• Amylyx Pharmaceuticals in its $200 million, $69 million and $246 million underwritten public offerings of common stock
• Ori Capital in its secondary sale of shares of CG Oncology in connection with CG Oncology’s $204 million common stock offering 
• The underwriters of The Pennant Group’s $125 million public offering of common stock
• The placement agent for Organogenesis Holdings’ $130 million offering of Series A convertible preferred stock
• The agents in connection with Medincell S.A.’s €48 million and €43 million global capital increases
• The underwriters of Outlook Therapeutics’ offering of common stock and warrants
• The underwriters of PACS Group’s $690 million primary and secondary follow on offering of common stock
• The underwriters of Inotiv’s $26 million follow on public offering and the agent in Inotiv’s $50 million at-the-market offering of common stock
• The underwriters and initial purchasers of KalVista Pharmaceuticals’ $160 million follow-on and $60 million follow-on and concurrent private offering of common stock
• The underwriters of Taysha Gene Therapies’ $75 million follow-on public offering of common stock and pre-funded warrants
• The underwriters and initial purchasers of Royalty Pharma’s $6 billion, $1.3 billion, $2.0 billion and $1.5 billion senior unsecured notes offerings
• The underwriters of PACS Group’s $517 million Initial Public Offering of common stock
• The agents in Silence Therapeutics’ $120 million private placement (PIPE) of American Depositary Shares
• Orchard Therapeutics in its $478 million acquisition by Kyowa Kirin
• The underwriters of Myriad Genetics’ $127 million follow-on public offering of common stock
• The initial purchasers of Enovis Corporation’s $460 million 3.875% convertible senior notes offering
• The initial purchasers of Amphastar Pharmaceuticals’ $345 million 2.00% convertible senior notes offering
• Compass Pathways in an up to $285 million private placement (PIPE) of American Depositary Shares and warrants to purchase American Depositary Shares 
• The agent in Taysha Gene Therapies’ $150 million private placement (PIPE) of common stock and pre-funded warrants
• The underwriters of CorMedix Inc.’s $85 million follow-on offering of common stock and $40 million follow-on offering of common stock and pre-funded warrants
• Karuna Therapeutics in its $400 million at-the-market (ATM) offering of common stock
• The initial purchasers of Zynex Inc.’s $60 million convertible senior notes offering
• The underwriters of Silence Therapeutics’ $56 million follow-on offering of American Depositary Shares
• Orchard Therapeutics in its up to $188 million private placement (PIPE) strategic financing transaction of ordinary shares and warrants
• Compass Pathways in its $150 million at-the-market (ATM) offering of American Depositary Shares
• The underwriters in multiple secondary follow-on public offerings of Privia Health Group shares totaling over $1.2 billion
• The agents in connection with the tax-free distribution of Ligand Pharmaceutical’s OmniAb antibody discovery business and the business combination of OmniAb Inc. with Avista Public Acquisition Corp. II and related deSPAC transaction
• The agent of Ligand Pharmaceutical’s $100 million at-the-market offering
• Amylyx Pharmaceuticals in its $190 million initial public offering 
• The agent of Calliditas Therapeutics’ $75 million at-the-market offering of American Depositary Shares
• The underwriters of Bionomics’ $23 million initial public offering of American Depositary Shares
• The agent of Silence Therapeutics’ $100 million at-the-market offering of American Depositary Shares
• The agent of VBI Vaccines’ $125 million at-the-market offering
• The initial purchasers of Dynavax’s $200 million convertible senior notes offering
• The underwriters of Privia Health Group’s $608 million initial public offering, inclusive of a $92 million concurrent private investment by Anthem, Inc.
• Orchard Therapeutics in its $150 million PIPE transaction
• The underwriters of BeyondSpring’s $86 million, $30 million and $25 million follow-on public offerings
• The underwriters of Royalty Pharma’s $2.5 billion initial public offering and $728 million follow-on public offering
• COMPASS Pathways in its $147 million initial public offering
• Checkmate Pharmaceuticals in its $75 million initial public offering and $50 million at-the-market offering
• The underwriters of ACell Inc’s initial public offering (withdrawn)
• The underwriters of Agile Therapeutics’ $45 million follow-on public offering
• argenx SE in its $557 million follow-on public offering
• The underwriters of eHealth’s $227 million follow-on public offering and $130 million inaugural follow-on public offering*
• BeiGene in its $900 million global public offering*
• ConforMIS’ $155 million initial public offering*
• ProQr Therapeutics’ $112 million initial public offering*
• Vascular Biogenics’ $40 million initial public offering*
• Evogene’s $85 million initial public offering*
• Retrophin’s $150 million follow-on public offering*
• AMAG Pharmaceuticals’ $201 million follow-on public offering*
• Sarepta Therapeutics’ $101 million follow-on public offering*
• Syndax Pharmaceuticals’ $53 million initial public offering*

*Denotes experience prior to joining Goodwin.

• GameChange Energy Technologies in the acquisition of certain assets of Terrasmart
• The initial purchasers of WhiteFiber’s $230 million offering of 4.5% convertible senior notes
• The placement agent in Schmid Group’s $30 million offering of senior convertible notes and warrants to purchase ordinary shares
• The underwriters of Vertical Aerospace’s $60 million public offering of ordinary shares and the agent in Vertical Aerospace’s $100 million at-the-market offering
• The initial purchasers in Blacksky Technology’s $185 million offering of convertible senior notes due 2033
• The agents in Sequan Communication’s $376 million offering of American Depositary Shares, convertible debentures and warrants
• The agents in Bitdeer Technologies Group’s $1.0 billion at-the-market offering of Class A ordinary shares 
• The initial purchasers of Galaxy Digital Holdings’ $403 million 2.5% exchangeable senior notes offering
• The initial purchasers of Bitdeer Technologies Group’s $325 5.00% and $400 million 5.25% convertible senior notes offering and the underwriters of Bitdeer’s $172 million 8.5% convertible senior notes offering
• PTC Inc. in a $827 million secondary block trade of its common stock
• GameChange Solar in its $150 million sale of convertible preferred stock and in a working capital line of credit
• The Underwriters of FTC Solar’s $258 million initial public offering
• SoFi Technologies in its business combination with Social Capital Hedosophia and related deSPAC transaction for a transaction value of $8.65 billion
• Verra Mobility’s $187 million inaugural public offering*
• The Underwriters of GreenSky’s $1.01 billion initial public offering* 
• The Underwriters on multiple follow-on public offerings by Kornit Digital* 
• YuMe’s $46 million initial public offering*
• Trulia’s $117 million initial public offering and $230 million follow-on public offering* 
• ExactTarget’s $186 million initial public offering and $194 million follow-on public offering*
• Ambarella’s $41 million initial public offering*
• Kayak Software’s $105 million initial public offering*
• Bazaarvoice’s $131 million initial public offering and $131 million follow-on public offering*
• LifeLock’s $184 million initial public offering*
• Boingo’s $78 million initial public offering*

*Denotes experience prior to joining Goodwin.

• The underwriters of J. Jill’s $71 million primary and secondary public offering of common stock
• The underwriters of Celsius Holdings’ $462 million follow-on public offering
• Del Frisco’s Restaurant Group’s $75 million initial public offering and $83 million, $147 million and $121 million follow-on public offerings*
• Amira Nature Foods’ $90 million initial public offering*

*Denotes experience prior to joining Goodwin.

• The underwriters of the $1.3 billion offering of tangible equity units and common stock and the underwriters of the  $173 million, $150 million and $138 million follow-on public offerings by VSE Corporation
• The underwriters of Ducummon Incorporated’s $92 million re-IPO
• Advance Disposal Service’s $380 million initial public offering*
• Atkore International Group’s $192 million initial public offering*
• SiteOne Landscape Supply’s $242 million initial public offering*
• Ryerson Holding’s $121 million initial public offering*
• Metaldyne Performance Group’s $172 million initial public offering*
• Colfax Corp.’s $633 million and $509 million follow-on public offerings*
• Constellium’s $376 million initial public offering and $342 million follow-on public offering*
• Armstrong World Industries’ $624 million follow-on public offering* 
• TriMas Corp.’s $37 million follow-on public offering*

*Denotes experience prior to joining Goodwin.

• Tremont Mortgage Trust’s $70 million initial public offering and concurrent private placement*
• Ladder Capital’s $259 million initial public offering and various follow-on equity and debt offerings* 
• Multiple public offerings by NorthStar Realty Finance* 
• Multiple public offerings by Kennedy-Wilson Holdings* 
• Ramco Gershenson Properties Trust’s $150 million and $114 million follow-on public offerings and $150 million at-the-market offering* 
• Strategic Hotels and Resorts’ $115 million follow-on public offering*
• Multiple follow-on public offerings by Armour Residential REIT*
• Boyd Gaming Corp.’s $228 million follow-on public offering*
• Isle of Capri Casinos’ $63 million follow-on public offering*

*Denotes experience prior to joining Goodwin.

• SoFi Technologies in its business combination with Social Capital Hedosophia and related deSPAC transaction for a transaction value of $8.65 billion
• Byline Bancorp’s $145 million initial public offering*
• Eagle Point Credit’s $100 million initial public offering and $25 million follow-on public offering*
• Oxford Lane Capital’s $68 million rights offering and $53 million follow-on public offering*
• Fly Leasing’s $184 million follow-on public offering*
• Solar Senior Capital’s $160 million initial public offering*
• Multiple public offerings by TCP Capital*
• TICC Capital’s $61 million follow-on public offering*

*Denotes experience prior to joining Goodwin.

• The direct listing on Nasdaq of common shares of The Metals Royalty Company
• Univar’s $886 million initial public offering and concurrent private placement*
• Pioneer Natural Resources’ $951 million follow-on public offering*
• Tallgrass Energy Partners’ $569 million follow-on public offering*
• PBF Energy’s $540 million follow-on public offerings*
• NGL Energy Partners’ $300 million inaugural follow-on public offering*

*Denotes experience prior to joining Goodwin.